Gastrointestinal neuromodulation and associated systems and methods
US11013549B2 · kind B2 · utility
Assignee
Inventors
Key dates
| Filing date | Mar 7, 2013 |
| Grant date | May 25, 2021 |
| Priority date | — |
| Expiry date | Jan 7, 2035 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61N2007/0043
- WIPO fieldMedical technology
- WIPO sectorInstruments
Abstract
Methods for treating gastrointestinal conditions, conditions associated with sympathetic and/or parasympathetic activity in the gastrointestinal organs, and conditions associated with central sympathetic and/or parasympathetic activity in a patient with therapeutic gastrointestinalneuromodulation and associated systems and methods are disclosed herein. One aspect of the present technology is directed to methods that at least partially inhibit sympathetic neural activity in nerves proximate a gastrointestinal artery of a gastrointestinal organ of a patient. Sympathetic drive in the patient can thereby be reduced in a manner that treats the patient for the gastrointestinal condition.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.